Ingela Björholt PhD, came up with the idea for MedTech20^® during her time as CEO for Nordic Health Economics AB, a company engaged in consultancy and research within the area of health economics, which later was acquired by PharmaLex GmbH in 2017.

 

After many years of preparing health-economic evaluations of pharmaceuticals, aimed for review of Pricing and Benefit Boards, the need for similar analyses of medical devices became apparent. Such products often have benefits beyond what can be measured using clinical variables. Clearly, something was missing, more precisely a method capturing the general wellbeing in users’ everyday life.

 

The team embraced the challenge and initiated a research project, it was published in 2017*).

 

MedTech20 was excluded in the acquisition of Nordic Health Economics and the rights now belong to NHE Licence AB.

​

​

*) Ref: Lesén E, Björholt I, Ingelgård A, Olson Fredrik J Exploration and preferential ranking of patient benefits of medical devices: a new and generic instrument for health economic assessments. Int J Technol Assessment in Health Care. 2017; 33 (4) , 463–71.